Study | Age (y) | FIGO stage | Size (cm) | Associated component | Metastatic site | Ascitic fluid cytology | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|
Eichhorn et al., 1996 [7] | 58 | IIIB | 30 | Mucinous borderline tumor with small foci of mucinous adenoCa | Appendix, peritoneum | N/A | TAH/BSO/OM/AP/LN & peritoneal biopsies + Chem | DOD 8 months |
Chen, 2000 [8] | 73 | IIIC | 11 | Microinvasive mucinous adenoCa | Small bowel serosa, retroperitoneal LN | N/A | BSO/OM/RPLN+ PTX/CDDP | DOD 8 months |
Choi et al., 2007 [25] | 71 | IIIB | 6.5 | Serous Ca | Retroperitoneum | N/A | TAH/BSO + PTX/CBDCA | NED 8 months |
Veras et al., 2007 [14] | 39 | IV | 26 | Mucinous adenoCa | N/A | N/A | TAH/BSO + platinum-based Chem | AWD 8 months |
42 | IV | N/A | Benign cyst & dermoid cyst in contralateral OV | N/A | N/A | TAH/BSO + platinum-based Chem | DOD 20 months | |
53 | III | 14.5 | Endometrioid adenoCa | N/A | N/A | TAH/BSO + platinum-based Chem | NED 37 months | |
47 | III | 14 | AdenoCa, not otherwise specified & mature teratoma | N/A | N/A | TAH/BSO + platinum-based Chem | NED 11 months | |
25 | IV | 5 | Mature cystic teratoma | N/A | N/A | BSO/OM/AP + platinum-based Chem | DOD 36 months | |
55 | III | 13.5 | Mucinous low malignant potential | N/A | N/A | TAH/BSO + platinum-based Chem | DOD 2 months | |
63 | IV | 14 | Endometrioid adenoCa | N/A | N/A | TAH/RSO + platinum-based Chem | DOD 9 months | |
Tsuji et al., 2008 [26] | 46 | IIIC | 12 | Squamous differentiation | Omentum, peritoneum, rectum, uterus | N/A (bloody 2 l) | subTAH/BSO/OM + PTX/CBDCA | DOD 4 months |
Dundr et al., 2008 [27] | 73 | IV | 9 | Pure LCNEC | Mesentery, left renal capsule, CNS | N/A | CNS meta resection/γ Knife + TAH/BSO/OM/mesenterial meta resection/left nephrectomy + PTX/CBDCA + γ Knife | NED 12 months |
Chenevert et al., 2009 [17] | 53 | 20 | IV | Mucinous adenoCa | Douglas pouch, lungs, mediastinal LN, liver, bone | N/A | TAH/BSO/OM/PLN/Douglas pouch resection + PTX/CBDCA | DOD 3 months |
Yasuoka et al., 2009 [28] | 36 | 26 | IIIA1 | Mucinous intraepithelial Ca | Periaortic LN | N/A | TAH/BSO/RPLN/OM + Chem | NED 6 months |
Draganova-Tacheva et al., 2009 [29] | 68 | IV | 18 | Serous Ca | Peritoneum, omentum, uterus, bladder, colon, diaphragm, inguinal LNs | Positive (papillary serous adenoCa) | NAC (PTX/CBDCA) + IDS (BSO/OM) + PTX/CBDCA | DOD 7 months |
Oshita et al., 2011 [18] | 66 | IV | 11 | N/A | Vagina, lungs | N/A | NAC (PTX/CBDCA) + IDS (TAH/BSO/OM/peritoneal biopsy) + PTX/CBDCA + brain meta resection & RT | NED 64 months |
42 | IIIB | 13 | Endometrioid adenoCa | Peritoneum | N/A | TAH/BSO/RPLN/OM/Douglas pouch resection+ PTX/CBDCA | NED 32 months | |
Miyamoto et al., 2012 [30] | 69 | IV | 15 | Mature cystic teratoma | Peritoneum, lungs, retroperitoneal & subclavian LNs | Ruptured | LSO/RPLN/subclavian LN biopsies + PTX/CBDCA | DOD 6 months |
Shakuntala et al., 2012 [31] | 40 | IIIC | 20 | Pure LCNEC | Omentum, paraaortic LN, bowel, bladder | N/A (minimal bloody) | BSO/OM/PAN/bladder & sigmoid colon deposit resection + CDDP/etoposide | NED 6 months |
Ki et al., 2014 [20] | 77 | IV | 15 | Pure LCNEC | Supraclavicular LN | Positive (malignant cells) | TAH/pelvic & neck masses resection + etoposide/CBDCA | DOD 45 days |
Cokmert et al., 2014 [32] | 68 | IV | 20 | AdenoCa | Uterus, bladder, sigmoid colon, omentum, lungs mediastinum LN, bones | N/A | TAH/BSO/RPLN/OM + RT | DOD 7 months |
Lin et al., 2014 [33] | 50 | IV | 25 | Pure LCNEC | Liver, pelvic wall, intestine, left tube, parametrium, omentum, appendix | N/A | TAH/BSO/OM + PTX/CBDCA | DOD 3 months |
Agarwal et al., 2016 [34] | 35 | IIIC | 6 | Pure LCNEC | Cervix, retroperitoneal LN | Negative | TAH + BSO | AWD 3 months |
Herold et al., 2018 [35] | 75 | IV | 13 | Pure LCNEC | Pelvic peritoneum, retroperitoneal LN, liver | N/A | Laparoscopy → BSO/RPLN/OM/pelvic peritoneum & liver resection + etoposide/CBDCA + PTX/CBDCA | NED 36 months |
Present | 31 | IIIC | 10 | Pure LCNEC | Peritoneum, omentum | Negative (bloody 7 l) | Diagnostic laparoscopy + etoposide/CDDP | DOD 3 months |